Position in AZN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$396,411,608
New position
Shares Held
2,009,997
first reported quarter
Ownership
0.130%
of shares outstanding
% of Portfolio
3.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 78.37603737717022.ToString("F0")%
Shared 0.ToString("F0")%
None 21.623962622829783.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Capital International, Inc./CA/ holds $919,638,265 across 11 Drug Manufacturers - General names. AZN ranks #1 (43.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
2,009,997 | $396,411,608 | |
| 2 | LLY |
ELI LILLY & Co
|
193,029 | $177,542,283 | |
| 3 | AMGN |
Amgen Inc
|
398,069 | $140,060,577 | |
| 4 | ABBV |
AbbVie Inc.
|
430,429 | $93,614,003 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
355,956 | $49,609,587 | |
| 6 | JNJ |
Johnson & Johnson
|
156,815 | $38,331,858 | |
| 7 | PFE |
Pfizer Inc
|
374,286 | $10,509,950 | |
| 8 | NVO |
Novo Nordisk A S
|
155,415 | $5,711,501 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $396,411,608 | 2,009,997 | Shares | Defined | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||